Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The transcription factor Evi-1.

H Hirai1

  • 1Department of Hematology and Oncology, Graduate School of Medicine, University of Tokyo, Japan. hhirai-tky@umin.ac.jp

The International Journal of Biochemistry & Cell Biology
|January 21, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Temporal and spatial distribution of DNA topoisomerase II alters during proliferation, differentiation, and apoptosis in HL-60 cells.

Blood·1998
Same author

Induction and inhibition of cytochrome P450 isoforms by imazalil, a food contaminant, in mouse small intestine and liver.

Xenobiotica; the fate of foreign compounds in biological systems·1998
Same author

Use of EBV-based Vector/HVJ-liposome complex vector for targeted gene therapy of EBV-associated neoplasms.

Biochemical and biophysical research communications·1998
Same author

c-Cbl is tyrosine-phosphorylated by interleukin-4 and enhances mitogenic and survival signals of interleukin-4 receptor by linking with the phosphatidylinositol 3'-kinase pathway.

Blood·1998
Same author

Time course analysis of semi-quantitative PCR and antigenaemia assay for prevention of cytomegalovirus disease after bone marrow transplantation.

British journal of haematology·1998
Same author

Loss of WT1 function leads to ectopic myogenesis in Wilms' tumour.

Nature genetics·1998

Evi-1 is a crucial transcription factor for embryonic development and cell proliferation. Its dysregulation is linked to myeloid leukemias, suggesting Evi-1 as a therapeutic target for cancer.

Area of Science:

  • Developmental Biology
  • Hematology
  • Oncology

Background:

  • Evi-1 is a transcription factor characterized by two zinc finger domains.
  • Its expression pattern in embryonic tissues suggests involvement in organogenesis and morphogenesis.
  • Evi-1 plays a role in developmental cell proliferation, vascularization, and cell signaling during midgestation.

Purpose of the Study:

  • To investigate the role of Evi-1 in mouse embryonic development.
  • To explore the association between Evi-1 expression and hematopoietic malignancies.
  • To identify potential therapeutic strategies targeting Evi-1.

Main Methods:

  • Analysis of Evi-1 expression patterns in embryonic tissues.
  • Study of Evi-1 knockout mouse models to assess developmental defects.

Related Experiment Videos

  • Examination of Evi-1's role in hematopoietic cell differentiation.
  • Investigation of Evi-1's association with myelogenous leukemias and myelodysplastic syndromes.

    • Main Results:

    • Mice lacking Evi-1 exhibit multiple embryonic defects and early mortality.
    • Evi-1 expression is transiently observed during myeloid cell differentiation.
    • Constitutive Evi-1 expression is linked to myelogenous leukemias and myelodysplastic syndromes in mice and humans.

    Conclusions:

    • Evi-1 is essential for normal embryonic development, including cell proliferation and vascularization.
    • Aberrant Evi-1 expression in hematopoietic cells contributes to leukemogenesis.
    • Repressing Evi-1 expression may offer a therapeutic approach for Evi-1-induced neoplastic tumors.